A study described by the Subburayan and their colleagues found that human glioma cells treated with thymoquinone showed inhibition in cell growth via inducing Par‐4 expression, which triggers cellular senescence and prostate apoptosis response‐4 (Par‐4) tumor suppressor protein expressions. Here, TCHP is linked to glioma.